Li et al. propose that CAMK2G, calcium/calmodulin-dependent protein kinase II gamma, regulates redox homeostasis upon cisplatin treatment by phosphorylating Inositol-Trisphosphate 3-Kinase B at serine 174, which drives cisplatin resistance in ovarian cancer [11]. The gene discussed is CAMK2G; the disease is ovarian cancer.